Switch to
More onapp

How to use scorecard? Learn more

Ortin Laboratories Ltd

ORTINLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15 cr, stock is ranked 3,890
High RiskStock is 4.83x as volatile as Nifty
19.200.20 (-1.03%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹15 cr, stock is ranked 3,890
High RiskStock is 4.83x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-3.85
PB RatioPB Ratio
1.44
Dividend YieldDiv. Yield
Sector PESector PE
51.18
Sector PBSector PB
5.82
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.

Financial TrendFinancial statements 

2020202120222023197.588.228.426.06-0.580.95-0.41-0.10
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnApr 11, 2024

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on April 11, 2024. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on April 11, 2024. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Price movement 
Announced OnApr 6, 2024

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response. | Download

Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response. | Download

Cash Dividend 
Ex. DateSep 24, 2013

Final • Div/Share: ₹ 0.25

See all events